함께 비교하는 진짜 ADC · Antibody · CGT 데이터

TQB2102 (TQB2102)

Breast Neoplasm; Breast Cancer · HER2

Benmelstobart (Benmelstobart)

Breast Neoplasm; Breast Cancer · HER2

TQB2868 (TQB2868)

Breast Neoplasm; Breast Cancer · HER2

HRS-4508 (HRS-4508)

Breast Neoplasm; Breast Cancer · HER2

SHR-4602 (SHR-4602)

Breast Neoplasm; Breast Cancer · HER2

Fluzoparib (Fluzoparib)

Breast Neoplasm; Breast Cancer · HER2

ADCBiologicstaleBiohaven Therapeutics Ltd.Phase 1

BHV-1530 (BHV-1530)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

AntibodystaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#항체#면역항체+3

AntibodystaleRochePhase 1

JS001+Bevacizumab (JS001+Bevacizumab)

Advanced Malignant Solid Tumors · Advanced Malignant Solid Tumors

#AdvancedMalignantSolidTumors#Antibody#Phase1#항체#면역항체+2

AntibodystaleRochePhase 3

serplulimab、bevacizumab (serplulimab、bevacizumab)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase3#항체#면역항체+2

ADCBiologicstaleBeOne MedicinesPhase 1

BG-C0979 (BG-C0979)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleSOTIO Biotech a.s.Phase 2

SOT102 (SOT102)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleVelaVigo Bio IncPhase 2

VBC101 (VBC101)

Participants With Advanced Solid Tumor Malignancies · Participants With Advanced Solid Tumor M

#ParticipantsWithAdvancedSolidTum#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

AntibodystaleRochePhase 3

Triamcinolone Acetonide and Bevacizumab (Triamcinolone Acetonide and Bevacizumab)

Diffuse Diabetic Macular Edema · Diffuse Diabetic Macular Edema

#DiffuseDiabeticMacularEdema#Antibody#Phase3#항체#면역항체+2

ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD48A (SGN-CD48A)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleAcepodia Biotech, Inc.Phase 1

ACE1831 (ACE1831)

B-cell Lymphoma; Non Hodgkin Lymphoma · B-cell Lymphoma

#B-cellLymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleBiOneCure Therapeutics Inc.Phase 2

BIO-106 (BIO-106)

Advanced Cancer; Advanced Solid Tumor · Advanced Cancer

#AdvancedCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleInnate PharmaPhase 1

IPH4502 (IPH4502)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleAxcynsis Therapeutics Pte LtdPhase 1

AT03-65 (AT03-65)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

AntibodystaleJanssenApproved

Infliximab-Innovator (Infliximab-Innovator)

Colitis, Ulcerative; Crohn's Disease · Colitis, Ulcerative

#ColitisUlcerative#Antibody#Approved#항체#면역항체+5

임상시험 1상태 ACTIVE

AntibodystaleJanssenPhase 3

Infliximab at weeks 0,4, and 8 (Infliximab at weeks 0,4, and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2

AntibodystaleJanssenPhase 3

Infliximab at weeks 0 and 8 (Infliximab at weeks 0 and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2

ADCBiologicstaleSalubris Biotherapeutics IncPhase 2

JK06 (JK06)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleElevation OncologyPhase 1

EO-3021 (EO-3021)

Stomach Neoplasm; Gastrointestinal Neoplasms · Stomach Neoplasm

#StomachNeoplasm#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 1%임상시험 1상태 DISCONTINUED

ADCBiologicstaleMacroGenicsPhase 1

MGC028 (MGC028)

Advanced Solid Tumors; NSCLC Adenocarcinoma · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2